CPG23DIAB

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameCPG23DIAB
Drug Alias NamePG23DIABCPG23DIAB
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelprogen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelprogen
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A